Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Radiother Oncol. 2018 Jun 28;128(3):442–451. doi: 10.1016/j.radonc.2018.06.013

Table 4.

Multivariate model regressing DIGEST grade ≥2 dysphagia after RT on clinical factors and RPA-derived dose thresholds.

Clinical and Dosimetric Nominal Multivariate Regression Analysis
Characteristic OR (95%CI) LogWorth FDR p-value

V61 of GHM ≥ 18.57% No 1 3.932 0.00012*
Yes 32.8 (5.69–335)
V55 of SPC ≥ 97.46% No 1 2.773 0.0017*
Yes 10.9 (2.7–57.5)
Treatment Modalities CCRT Only 1 1.723 0.0189*
IC+CCRT 10.64 (2.27–65.72)
RT alone 0.79 (0.005–19.02)
T Stage 0–2 1 1.279 0.0526
3–4 5.29 (1.16–28.58)
RT Dose 1 (1.0002–1.009) 1.279 0.0526
Baseline DIGEST 0–1 1 0.517 0.3037
2–3 1 (0.36–42.9)

BIC=101.6, AICc=81.09, AUC=0.909